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The prevalence of multidrug resistance among clinically significant bacteria calls for the
urgent development of new antibiotics with novel mechanisms of action. In this study, a
new small molecule exhibiting excellent inhibition of bacterial cell division with potent
antibacterial activity was discovered through cell-based screening. The compound
exhibits a broad spectrum of bactericidal activity, including the methicillin-resistant
Staphylococcus aureus, vancomycin-resistant Enterococcus and NDM-1 Escherichia
coli. The in vitro and in vivo results suggested that this compound disrupts the dynamic
assembly of FtsZ protein and Z-ring formation through stimulating FtsZ polymerization.
Moreover, this compound exhibits no activity on mammalian tubulin polymerization and
shows low cytotoxicity on mammalian cells. Taken together, these findings could provide
a new chemotype for development of antibacterials with FtsZ as the target.
Keywords: bacterial resistance, antibacterial activity, cell division, FtsZ inhibitor, FtsZ polymerization
INTRODUCTION
Treatment of antibiotic-resistant bacterial infections is becoming more difficult because bacteria
develop resistance to conventional antibiotics at an alarming speed (Payne et al., 2007; Arias and
Murray, 2009; Silver, 2011; Wright, 2012). Methicillin-resistant Staphylococcus aureus (MRSA) and
vancomycin-resistant Enterococcus faecium (VREF) are typical examples of Gram-positive bacteria
which have already shown resistance to the wildly prescribed antibiotics including methicillin and
vancomycin (Gould et al., 2012; Humphries et al., 2013). This situation is also alarming for Gram-
negative bacteria. The World Health Organization (WHO) has just released a list of the drug-
resistant bacteria which new antibiotics are desperately needed. In this list, carbapenem resistant
Gram-negative organisms are in the critical priority (Willyard, 2017). In addition, Superbugs with
New Delhi metallo-beta-lactamase-1 (NDM-1) are known to be highly resistant to most antibiotics
and only tigecycline and colistin are still effective nowadays (Kumarasamy et al., 2010; Walsh et al.,
2011). Therefore, new types of antibacterial agents with new molecular scaffolds and mechanisms
of action are urgently needed (Devasahayam et al., 2010; Wright, 2012).
Understanding bacterial cell division is believed to be critical in new antibiotic development
because cell division is an essential process for bacterial survival and the bacterial divisome
possesses a complex set of biochemical machinery that contains many proteins as potential
drug targets. Among these proteins, filamenting temperature-sensitive mutant Z (FtsZ)
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has been identified as a very critical protein that can influence
bacterial cell division and it is highly conserved in a wide range
of bacteria (Erickson, 1995, 1997; Margolin, 2000; Addinall and
Holland, 2002). During bacterial cytokinesis, FtsZ assembles
into a highly dynamic cytoskeleton scaffold (the Z-ring) by
undergoing GTP-dependent polymerization, generating head-to-
tail protofilaments and assembling into bundles at the site of
septum formation (Bi and Lutkenhaus, 1991; Oliva et al., 2004;
Li et al., 2013). Subsequently, FtsZ recruits other downstream
proteins responsible for the invagination of cell membrane
and septum formation, completing the bacterial cell division
(Margolin, 2005; Adams and Errington, 2009).
The high conservation and functional importance among
antibiotic-sensitive and antibiotic-resistant bacteria established
FtsZ as an attractive target for the development of new
therapeutic agents. In recent years, a number of small molecule
inhibitors of FtsZ have already been revealed to perturb FtsZ
polymerization and inhibit bacterial cell division (Bierer et al.,
1998; Beuria et al., 2005; Schaffner-Barbero et al., 2012; Li
et al., 2015; Haranahalli et al., 2016; Hurley et al., 2016;
Qiang et al., 2016; Bi et al., 2017). These studies suggest that
the molecules impair bacterial growth through disrupting the
dynamic assembly or/and GTP hydrolysis of FtsZ. Regarding
synthetic inhibitors, PC190723 is the most studied compound so
far (Haydon et al., 2008, 2010; Andreu et al., 2010; Adams et al.,
2011; Elsen et al., 2012; Tan et al., 2012). This difluorobenzamide
derivative enhances FtsZ polymerization and exhibits potent
antibacterial activity [e.g., MIC (MRSA) = 1 µg/mL], but
exerts little effect on gram-negative strains (Haydon et al.,
2008). In order to improve the pharmacological properties of
PC190723, Kaul et al. (2013a,b, 2015) designed and synthesized
some prodrugs of PC190723, these drug candidates showed
superior antibacterial potencies and improved pharmacokinetic
profiles compared with PC190723. Among the natural products,
berberine and its 9-phenoxyalkylberberine derivatives block the
protein assembly and inhibit the GTPase of FtsZ (Domadia
et al., 2008; Sun et al., 2014). Compounds from these derivatives
exhibited strong antibacterial actives against MRSA and VREF
[MIC values = 2–8 µg/mL]. These berberine analogs also
showed a moderate inhibition on the growth of Gram-negative
bacteria such as E. coli and K. pneumoniae with MIC values
of 32–128 µg/mL (Sun et al., 2014). Last but not least, a
few peptidic inhibitors have also been studied. Among these
peptides, the cyclic octapeptides design by Pieraccini et al. (2013)
via computational method showed strong perturbed effects on
GTPase of FtsZ and notable inhibition of FtsZ polymerization.
To expand the existing chemical diversity with innovative
chemotypes targeting bacterial cell division seems an
opportunity. In this study, we have focused our efforts on
the identification of new small molecules that block the
bacterial cell division process and disrupt FtsZ activity, and
successfully identified a potent cell division inhibitor, 2-((E)-4-
Hydroxystyryl)-1-methyl-4-((Z)-(3-methylbenzo[d]thiazol-2
(3H)-ylidene)methyl)quinolin-1-ium iodide (1), by cell-based
screening (Figure 1). The results obtained suggest that this new
FtsZ targeting compound inhibits bacterial cell division with
high antibacterial activity.
FIGURE 1 | Chemical structures of 1.
MATERIALS AND METHODS
Cell Division Inhibitory Screening Assay
Cell division inhibitory activity of the tested compounds was
performed as described previously (Stokes et al., 2005). Overnight
B. subtilis culture was grown in starvation medium supplemented
with 1% hydrolyzed casein and then diluted in starvation
medium supplemented with 3% hydrolyzed casein and grown
at 37◦C. The culture was diluted to A600 of ∼0.06, and 10 µL
aliquots were added to transparent 96-well microtiter plates
containing dilutions of the screening compounds in 100 µL
volumes of medium. After incubation for approximately 5 h (4–5
generations) at 37◦C, 20 µL culture samples were transferred to
poly-L-lysine-coated slides for microscopy. Cell morphology was
assessed by phase-contrast light microscopy.
Antimicrobial Susceptibility Assay
B. subtilis, S. aureus USA300 #417 and S. aureus USA300 #2690
tested in this assay were already available in our in-house
collection, S. pyogenes (ID:0716100032) and S. agalactiae
(ID:0216100214) are clinical isolated strains in the First Affiliated
Hospital of Guangzhou Medical University, other strains were
purchased from American Type Culture Collection (ATCC,
USA). Antimicrobial susceptibility tests were conducted in
96-well microplates using the broth microdilution procedure
described in the Clinical and Laboratory Standards Institute
(CLSI) guidelines (Wikler et al., 2009). Cation-adjusted Mueller
Hinton broth for all the S. aureus strains, or Brain Heart
Infusion broth for antibiotic-susceptible E. faecium strain ATCC
49624, vancomycin-resistant E. faecium strain ATCC 700221,
S. agalactiae ATCC 13813, S. pyogenes ATCC 12344, S. pyogenes
ATCC 19615 and M. catarrhalis ATCC 25240, or Mueller Hinton
broth for the other strains were used in the assays. After
incubation for 18 h at 37◦C, the absorbance at 600 nm (A600)
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was recorded using a microplate reader (Bio-Rad laboratory Ltd.,
UK) and the percentage of bacterial cell inhibition with respect
to vehicles (1% DMSO) was calculated. The MIC was defined
as the lowest compound concentration at which the growth of
bacteria was inhibited by ≥90%. Three independent assays were
performed for each test.
Time-Killing Curve Assay
A growing culture of S. aureus ATCC 29213 or E. coli
ATCC 25922 were diluted to approximately 105 CFU.mL−1 in
volumes of Cation-adjusted Mueller Hinton broth or Mueller
Hinton broth, respectively, containing various concentrations of
compound 1. Cultures were incubated at 37◦C, shaking. At the
appropriate time intervals, 100 µL samples were removed for
serial dilution in 900 µL volumes of Mueller Hinton broth and
100 µL volumes from three dilutions were spread on to MH agar.
Cell counts (CFU.ml−1) were enumerated after incubating the
plates at 37◦C for 18 h.
Monitoring FtsZ Assembly with Light
Scattering
Staphylococcus aureus and E. coli FtsZ was cloned, overexpressed,
and purified as described previously (Sun et al., 2014; Li
et al., 2015). The light scattering assay was performed using a
protocol adapted from the literature (Andreu et al., 2010). The
polymerization of recombinant SaFtsZ or EcFtsZ was measured
using 90◦ light scattering in a thermostatically (37◦C) controlled
fluorescence spectrometer (Agilent Cary Eclipse). Both excitation
and emission wavelengths were set to 600 nm with a slit width
of 2.5 nm. FtsZ (6 µM) in 20 mM of Tris buffer (pH 7.4,
containing 0.01% Triton X-100 to avoid compound aggregation)
was placed in a 10× 2 mm (excitation path) cell, the reaction was
started by consecutive additions of 20 mM KCl, 5 mM MgCl2,
1 mM GTP and different concentrations of the test compound.
One percentage DMSO and 20 µg/mL methicillin were tested as
vehicle and negative in this assay.
Transmission Electron Microscopy (TEM)
Staphylococcus aureus FtsZ (12 µM) was incubated in the absence
and in the presence of 3 µg/mL of 1 in 50 mM MOPS buffer
(pH 6.5) at 25◦C. After 10 min, 5 mM MgCl2, 50 mM KCl, and
1 mM GTP were added to the reaction mixtures and incubated
at 37◦C for 15 min. Then, 10 µL of the sample mixtures were
placed on a glow-discharged Formvar carbon-coated copper grid
(400 mesh) for 10 min. The grids were subsequently subjected
to negative staining using 10 µL of 0.5% phosphotungstic acid
(PTA) for 30 s, air-dried and digital images of the specimen were
observed with a transmission electron microscope (JEOL model
JEM 2010) operated at 200 kV and equipped with a Gatan MSC
794 CCD camera.
GTPase Activity Assay
The Effect of 1 on the GTPase activity of recombinant
FtsZ was measured in 96-well microplates using a CytoPhos
phosphate assay Biochem Kit (Cytoskeleton, USA) according to
an optimized protocol and the manufacturer’s instructions. FtsZ
(6 µM) was preincubated with vehicle (1% DMSO) or different
concentrations of each test compound in 20 mM Tris buffer
(pH 7.4, containing 0.01% Triton X-100 to avoid compound
aggregation) for 10 min at 25◦C. Then 5 mM of MgCl2 and
200 mM of KCl were added. Reactions were started with the
addition of 500 mM GTP and incubated at 37◦C. After 30 min,
the reactions were quenched by adding 100 mL of Cytophos
reagent for 10 min. Inorganic phosphate was quantified by
measuring the absorbance at 650 nm with a microplate reader
(Bio-Rad laboratory Ltd., UK).
Monitoring Secondary Structural
Changes of FtsZ
SaFtsZ (10 µM) was incubated without or with 1 at different
concentrations (3 and 6 µg/mL) in 20 mM Tris buffer (pH 7.4,
containing 0.01% Triton X-100 to avoid compound aggregation)
for 30 min at 25◦C. The far-UV CD spectrum was monitored
over a wavelength range of 200–250 nm using a JASCO J-810
spectropolarimeter equipped with a temperature controller and
a 0.1 cm path length quartz cuvette. An average of five scans was
taken for each spectrum. Deconvolution and statistical analysis of
the CD spectra were performed using Jasco software and Origin
6.0 software, respectively.
Z-Ring Visualization in B. subtilis Cells
A culture of B. subtilis containing the IPTG-inducible plasmid for
the overexpression of green fluorescence protein (GFP)-tagged
FtsZ was grown in LB medium supplemented with 30 µg/mL
of chloramphenicol. After overnight incubation, a sample of the
culture was diluted to 1% in the LB medium containing 1 µg/mL
of 1 and 40 µM of IPTG. After 4 h incubation at 37◦C, the
B. subtilis cells were fixed, harvested and resuspended in PBS
buffer containing 0.25% of agarose. 10 µL of sample mixture were
added to a pretreated microscopic slide with 0.1% (w/v) poly-
L-lysine and visualized using a fluorescence microscope at 60×
oil immersion magnification with a standard FITC filter set. The
images were captured using an Olympus Bio Imaging Navigator
FSX 100 microscope.
Molecular Docking Simulation of
Compound 1
The molecular modeling procedures were performed using the
MolSoft ICM 3.8.4 software (Neves et al., 2012). The X-ray
crystal structure of S. aureus FtsZ in complex with a cell division
inhibitor (PC190723) and GDP was downloaded from the PDB
database (PDB entry: 4DXD; resolution: 2.0 Å) (Tan et al., 2012).
Water molecules and co-crystal ligands were removed from the
structure and the protein was prepared for docking using an
automated procedure of ICM. Briefly, the hydrogen atoms were
added to the structure, MMFF atom types and charges were
assigned, and His, Asn and Gln residues were optimized to the
best hydrogen bonding network. Energy maps accounting for
hydrogen bonding, van der Waals, hydrophobic and electrostatic
interactions were pre-calculated for two possible binding sites
centered at either the co-crystal ligand PC190723, or at the GDP
molecule. Each putative binding site was defined as a cubic
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grid including all FtsZ residues within a 10 Å cutoff from the
co-crystal structure. The grid spacing was set to 0.5 Å. The
structure of 1 was sketched in 2D and converted into 3D using
the ICM molecule editor. The molecules was flexibly docked
against the pre-calculated grid potential maps and scored using
the ICM scoring function. One hundred independent docking
runs were performed and the results were clustered in order
to filter repeated binding modes. The top-scoring poses were
visually inspected.
Effects on Eukaryotic Tubulin
Polymerization
The effects of 1 on eukaryotic tubulin polymerization were
monitored by fluorescence microscopy via using a tubulin
polymerization assay kit (BK011P, Cytoskeleton, Inc). A known
tubulin polymerization enhancer (paclitaxel) and a known
inhibitor of tubulin-dependent GTP hydrolysis (vinblastine)
were tested as reference compounds in the same assay conditions.
The concentration of 1 (20 µM) in this assay is much higher than
that in the FtsZ polymerization assay, to make sure whether this
compound has an effect on tubulin or not.
Cytotoxicity Test of Compound 1
L929 mouse fibroblasts cells and HK-2 renal epithelial cells
were removed from the sterile cell culture flasks with trypsin
and neutralized with fetal bovine serum. After washing
with phosphate buffered saline and centrifugation, cells
were re-suspended in complete cell culture medium and
the concentration was adjusted at approximately 1 × 105
cells mL−1. Cells seeded in the 96 wells microtiter plates for
24 h were used for the evaluation of the tested compounds.
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) was purchased from
Promega (Madison, WI, USA). For the MTS assay, cells (5,000
per well) were seeded into 96-well plates. After treatment with
compounds of different concentrations for 24 h, cells were added
with MTS at a final concentration of 0.3 mg/mL, followed by
incubation for another 2 h. The optical density (OD) of each well
was determined at 490 nm (background subtraction at 690 nm)
by a SpectraMax 340 microplate reader (Molecular Devices,
Sunnyvale, CA, USA). The growth inhibitory ratio was calculated
as follows: Growth inhibitory ratio= (Acontrol −Asample)/Acontrol
(where A is the OD value per well).
Antimicrobial Study of Compound 1
under Different Nutrient Conditions
To determine the growth curves of this assay, a single colony of
B. subtilis was inoculated in 10 mL LB or 10−2 LB at 37◦C for
24 h with shaking. The culture was harvested by centrifuging at
13,000 rpm for 5 min at 4◦C, and the cells were diluted with
LB or 10−2 LB to 0.5 McFarland standard (approximate cell
density is ∼108 CFU.mL−1). Aliquot of 10 µL 0.5 McFarland
standard cultures were diluted into 10 mL LB or 10−2 LB
containing various concentrations of compound 1, respectively.
Cultures were incubated at 37◦C with shaking. At appropriate
time intervals, 100 µL samples were taken from the culture
solution for serial dilution in 900 µL of the cultured medium
broth and 100 µL from three dilutions were spread over MH
agar. Cell counts (CFU.ml−1) were enumerated after the plates
incubated at 37◦C for 18 h. For the morphology observation,
B. subtilis cells were cultured in LB or 10−2 LB for 24 h without
or with 0.75 µg/mL of 1. Then 20 µL culture samples were
transferred to poly-L-lysine-coated slides for microscopy. Cell
morphology was assessed by phase-contrast light microscopy.
Synthesis and Characterization of
Compound 1
Refer to the Scheme S1 and Figures S3–S6 in the Electronic
Supplementary Material.
RESULTS
Compound 1 Induced Bacterial Cell
Elongation
FtsZ targeting compounds can disrupt the cell division function
of FtsZ protein, leading rod-shaped bacteria into cell elongation.
Because most of the reported FtsZ inhibitors do not have or
only have weak inhibitory effect against the Gram-negative
strains (Haranahalli et al., 2016; Hurley et al., 2016), we therefore
initiated the screen with B. subtilis 168 in the presence of a small
compound library including 40 natural products, 20 natural
product derivatives and 140 general compounds which are
either commercially available or synthesized in our laboratory.
The screen (Stokes et al., 2005; Li et al., 2015) generated one
potential hit, 2-((E)-4-hydroxystyryl)-1-methyl-4-((Z)-(3-
methylbenzo[d]thiazol-2(3H)-ylidene)methyl)quinolin-1-ium
iodide (compound 1). As shown in Figure 2B, 1 is able
to increase the cell length of B. subtilis significantly at low
concentration (1 µg/mL), as compared to untreated cells
(Figure 2A), suggesting a mechanism of antibacterial-induced
cell filamentation.
Antibacterial Activity of Compound 1
We further tested the antibacterial activity of 1 against an
extended panel of clinically relevant bacterial strains, including
antibiotic-resistant strains. Methicillin and ceftazidime were
tested under the same assay conditions as a reference compound.
The results showed that 1 has potent and broad spectrum
antibacterial activity against most of the Gram-positive and -
negative strains which were tested, as well as all strains and
species of Staphylococci that were tested [minimal inhibitory
concentration (MIC) in the range of 0.75–3.0 µg/mL], including
nine MRSA strains (Table 1). 1 can inhibit the growth of
antibiotic-susceptible and antibiotic-resistant S. aureus strains
with MIC values of 1.5–3 µg/mL, revealed that 1 have a better
anti-S. aureus effect than methicillin and ceftazidime (Table 1).
The potency of 1 was more than 100 times greater than that
of methicillin against most of the MRSA strains. The growth
of vancomycin-susceptible and vancomycin-resistant E. faecium
were inhibited with MIC values of 0.75–1.5 µg/mL. For Gram-
negative strains, 1 strongly inhibited the growth of E. coli and
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FIGURE 2 | Inhibition of cell division by 1. Cells of B. subtilis 168 were grown in the absence (A), and presence of 1 µg/mL of 1 (B). Scale Bar = 15 µm.
TABLE 1 | Minimum inhibitory concentrations of 1 against a panel of
bacterial strains.
Organism MIC (µg/mL)
1 Methicillin Ceftazidime
B. subtilis 168 1.5 <1 3
S. aureus ATCC 29213 1.5 <1 6
S. aureus ATCC 29247 1.5 6 12
S. aureus ATCC 33591a 3 1024 >48
S. aureus ATCC 33592a 1.5 512 >48
S. aureus ATCC 43300a 1.5 512 48
S. aureus ATCC BAA-41a 3 1024 >48
S. aureus ATCC BAA-1717a 3 512 >48
S. aureus ATCC BAA-1720a 3 1024 >48
S. aureus ATCC BAA-1747a 3 256 48
S. aureus USA300 #417a 3 512 >48
S. aureus USA300 #2690a 3 256 48
S. epidermidis ATCC 12228 0.75 0.75 1.5
E. faecalis ATCC 29212 0.75 0.75 1.5
E. faecium ATCC 49624 0.75 1.5 3
E. faecium ATCC 700221b 1.5 1.5 3
E. coli ATCC 25922 3 3 3
E. coli ATCC BAA-2469c 3 >1024 >48
S. pyogenes ATCC 12344 1.5 ND <1.5
S. pyogenes ATCC 19615 1.5 ND <1.5
S. agalactiae ATCC 13813 1.5 ND 1.5
M. catarrhalis ATCC 25240 3 ND <1.5
P. aeruginosa ATCC BAA-2108d 6 >256 6
K. pneumoniae ATCC BAA-1144e 48 >256 48
A. baumannii ATCC 19606 48 >256 24
Methicillin was used as a positive control in this test. aThese strains are MRSA;
bA vancomycin-resistant strain, MIC of vancomycin is higher than 96 µg/mL
(Sun et al., 2014); cA NDM-1 expressing strain, which is resistant to most of
the antibiotics, except tigecycline and colistin; dAn multidrug resistant strain; eAn
AmpC beta-lactamase expressing strain. ND = not detect.
its drug resistant strain, an NDM-1 carbapenemase isolate that
is resistant to many of the major classes of antibiotics, with
MIC values of 3 µg/mL. The growth of clinical isolated strains,
Streptococcus pyogenes and S. agalactiae were inhibited with
MIC values of 1.5 µg/mL. M. catarrhalis ATCC 25240 and
P. aeruginosaATCC BAA-2108 were inhibited with MIC values of
3 µg/mL and 6 µg/mL, respectively. In addition, 1 also showed a
moderate antibacterial activity against Klebsiella pneumoniae and
Acinetobacter baumannii strains with MIC values of 48 µg/mL,
which are close to that of ceftazidime (Table 1).
Time-Killing Curve Determinations
Viable counts for the determination of killing curves were
performed as previously described to investigate whether the
antibacterial activity of 1 is bactericidal or not (Wikler et al.,
2009). Sample killing curves resulting from 1 against S. aureus
ATCC 29213 and E. coli ATCC 25922 are presented in Figure 3.
The control showed no reduction in the counts of CFU
from control inoculum. Figure 3A showed that 1 at 1× MIC
concentration caused a reduction of 1 × 102 CFU mL−1 for
S. aureus in 4 h and to below the lowest detectable limit (103 CFU
mL−1) in 24 h. In the E. coli bacterial survival assay, 4×MIC of 1
can rapidly reduce the viable counts below the lowest detectable
limit after 4 h incubation, and the counts at MIC concentration
were maintained under the lowest detectable limit for over 24 h
(Figure 3B). The results revealed that the antibacterial activity
was consistent with a bactericidal mode of action.
Compound 1 Disrupts FtsZ Function In
Vitro
It is interesting to note that similar cell filamentation phenomena
were also found with FtsZ inhibitors from different chemotypes,
such as 9-phenoxyalkyl substituted berberine derivatives and
PC190723 (Haydon et al., 2008; Sun et al., 2014), suggesting
that 1-induced cell elongation may be attributed to the 1-FtsZ
interaction. To confirm whether this compound is able to disturb
FtsZ activity in vitro, S. aureus FtsZ and E. coli FtsZ were
cloned, overexpressed, and purified, and some biochemical assays
were employed. As a first step to validate that FtsZ is the
target of 1, we assessed the impact of 1 on the polymerization
dynamics of FtsZ using 90◦ light scattering in a thermostatically
(37◦C) controlled fluorescence spectrometer in which changes in
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FIGURE 3 | Time-killing curve and bacterial survival curve for 1. At time zero, samples of a growing culture of S. aureus ATCC 29213 were incubated with
concentrations of 1 equivalent to 1× (red), 2× (green), 4× (blue), or 8× (cyan) the MIC (A). Samples of a growing culture of E. coli ATCC 25922 were incubated with
concentrations of 1 equivalent to 1× (red), 2× (green), or 4× (blue) the MIC (B). Vehicle (1% DMSO; black) was included. Samples were removed at the time
intervals indicated for the determination of viable cell counts.
FtsZ polymerization are reflected by corresponding changes in
absorbance at 600 nm (Chan et al., 2015). Figure 4A shows the
time-dependent polymerization profiles of SaFtsZ in the absence
and presence of 1 at a concentration range from 1 to 6 µg/mL.
The similar phenomena can be observed in the time-dependent
polymerization profiles of EcFtsZ with 1 (Supplementary Figure
S1). These results prove that 1 stimulates FtsZ polymerization
in a concentration-dependent manner, which is similar to that
of some FtsZ-targeting compounds (Andreu et al., 2010; Kaul
et al., 2012, 2013b, 2015; Kelley et al., 2012). Methicillin is also
included in the assay as a non-FtsZ-targeting control antibiotic
and, as expected, it does not affect FtsZ polymerization. The
effect of 1 on FtsZ polymer formation was also visualized
using transmission electron microscopy (TEM) (Kaul et al.,
2012). It was found that the size and thickness of the FtsZ
polymers and the bundling of the FtsZ protofilaments were
drastically increased with 1 (Figures 4B,C). At 3 µg/mL of 1,
the thickness of FtsZ protofilaments was found to have increased
from ∼10 nm to ∼90 nm (Figure 4C). We further tested
the inhibitory effect of 1 on the GTPase activity of FtsZ. The
effects of various concentrations of 1 on the GTPase activity of
SaFtsZ or EcFtsZ were estimated after 30 min of FtsZ assembly.
The results shown that 1 decreased the rate of GTP hydrolysis
of FtsZ in a concentration-dependent fashion (Figure 4D and
Supplementary Figure S2). For example, 1, 4, and 8 µg/mL
of 1 inhibited GTPase activity of SaFtsZ by 14, 38, and 58%,
respectively (Figure 4D). The results indicate that 1 inhibits
the rate of GTP hydrolysis of FtsZ may due to modulating
the assembly of FtsZ. Apart from polymerization and GTPase
assays, the effects of 1 on the secondary structures of FtsZ
were determined by monitoring far-UV CD spectra of FtsZ
(Figure 4E). The results revealed that 1 can significantly perturb
the secondary structures of FtsZ. By analysis of the CD spectra
using Yang’s reference, it indicated that the secondary structure
of FtsZ contained ∼31.5% α-helix, ∼21.1% β-sheet, and ∼47.4%
other structures. When using 6 µg/mL of 1, α-helix increased
to ∼37.6% and β-sheet decreased to 14.2%. These confirmation
changes may also be the cause of disruption of FtsZ function.
Effect of Compound 1 on the Z-Ring
Formation
In addition to in vitro study, on-target effect of 1 in live
bacteria is also important. A green fluorescent protein (GFP)-
FtsZ constructed in B. subtilis 168 was used to monitor the impact
of the compound on the formation of FtsZ Z-rings (Stokes et al.,
2005). We treated the bacteria with DMSO (solvent control),
or 1 and examined the bacteria using fluorescence microscopy.
In the absence of compound, fluorescent foci corresponding
to Z-rings are evident at midcell (Figure 5A). In contrast, the
1-treated bacteria lack these midcell foci, and FtsZ was found to
distribute as discrete and punctate foci throughout the elongated
cell, indicating mislocalization of the FtsZ protein (Figure 5B).
As 1 enhances FtsZ polymerization, it is likely that those discrete
and punctate fluorescent foci in 1-treated bacteria are multiple
non-functional FtsZ polymeric structures. Observation of such
disorganized FtsZ in elongated bacterial cells is typical of agents
that disrupt FtsZ polymerization (Hurley et al., 2016).
Predicted Binding Mode of Compound 1
A 2.01 Å crystal structure of S. aureus FtsZ apo-form (Tan et al.,
2012) was used to identify a potential binding site for 1. The
highest docking score positioned the ligands bind near the T7-
loop and H7-helix. Since the binding site is a relatively narrow
cleft delimited by the H7-helix, the T7-loop, and a four-stranded
β-sheet, the substrate requires some degree of planarity in its
structure to fit in. The docking result suggested a large number of
favorable hydrophobic interactions between the molecule and the
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FIGURE 4 | Impact of 1 on the polymerization and GTPase activity of S. aureus FtsZ. (A) Time-dependent polymerization profiles of S. aureus FtsZ in the
absence and presence of 1 at a concentration range from 1 to 6 µg/mL. (B,C) Electron micrographs of S. aureus FtsZ polymers in the absence (B) and in the
presence (C) of 3 µg/mL of 1. Scale Bar = 500 nm. (D) The amount of Pi released per mol SaFtsZ in the absence and presence of various concentrations of 1.
(E) The CD spectra of FtsZ in the absence and presence of 1 at a concentration range from 3 to 6 µg/mL.
FIGURE 5 | Effect of Z-ring formation of 1 on B. subtilis. Bacteria were grown in the absence (A), and presence of 1 µg/mL of 1 (B). Scale Bar = 10 µm.
side chains of Leu200, Val203, Leu209, Met226, Ile228, Leu261,
Val297, Leu302, Val307, and Ile311. Moreover, the hydroxyl
group of 1 was predicted to participate in two hydrogen bonds
with the backbone carbonyl of Val203 and the backbone amide of
Leu209 (Figure 6).
Compound 1 Exerts Little or no Impact
on the Mammalian Tubulin
Tubulin is the closest mammalian functional homolog to
bacterial FtsZ. We therefore sought to determine whether 1
would exert a similar effect on mammalian tubulin because
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FIGURE 6 | Predicted binding mode of 1 against the S. aureus FtsZ. (A) Binding site surface colored by ligand binding properties (green = hydrophobic,
red = hydrogen bond acceptor propensity, blue = hydrogen bond donor propensity). The predicted binding mode of compound 1 is shown in a “ball and sticks”
representation (light yellow = carbon, blue = nitrogen, red = oxygen, yellow = sulfur, white = polar hydrogen). (B) FtsZ residues in close contact with 1 are labeled and
shown in a “ball and sticks” representation. Hydrogen bonds are represented with blue spheres.
our results (Figure 4) indicated that the compound is a
potent stimulator of FtsZ polymerization. In the presence of
vinblastine (30 µM), a tubulin inhibitor, the polymerization
of mammalian tubulin was completely inhibited. On the
opposite, the fluorescence intensity was significantly increased
in the presence of paclitaxel (20 µM), confirming that the
rate of polymerization was significantly enhanced. 1 (20 µM)
showed similar results to a control experiment with 2%
DMSO-treated mammalian tubulin, indicating that 1 is not a
stimulator/inhibitor of tubulin polymerization (Figure 7).
Cytotoxicity of Compound 1
To probe for any potential mammalian cytotoxicity, we used a
MTS tetrazolium assay to assess the cytotoxicity of 1 against two
mammalian cell lines (L929, HK-2). 1 was found to be minimally
toxic to these cell types, with 50% inhibitory concentrations
(IC50s) higher than 50 µg/mL (Table 2), which are much higher
than the MICs (0.75–3.0 µg/mL) of 1 against bacterial strains,
indicating no significant toxicity toward normal mammalian
cells.
Antimicrobial Study of Compound 1
under Different Nutrient Conditions
Bacteria change their size and growth rate when cultivated in
nutrient poor medium (Chien et al., 2012; Mandal et al., 2013).
It was reported that bacteria were more resistant to beta-lactam
antibiotics in a rich medium than in a relatively poor medium
(Wang et al., 2015). To further investigated the antimicrobial
activity of Compound 1 under different nutrient conditions,
we investigated the growth curves of B. subtilis 168 cells in
LB or 10−2 LB medium with different concentrations of 1.
And also observed the morphology of B. subtilis growing in
FIGURE 7 | Effect of 1 on the polymerization of mammalian tubulin.
(Blue) Tubulin was treated with 1% DMSO; (Green) Tubulin was treated with
20 µM of 1; (Red) Tubulin polymerization was enhanced by 20 µM of
paclitaxel; (Black) Tubulin polymerization was inhibited by 30 µM of vinblastine.
the two different nutrient conditions. The results indicated that
B. subtilis cells cultured in a nutrient rich medium have a faster
growth rate and longer morphology than that cultured in the
nutrient poor medium (Figures 8, 9). Figure 8A showed that
1 at 1.5 µg/mL decreased the cell numbers of B. subtilis below
the lowest detectable limit (103 CFU mL−1) after incubation for
6 h; however, using 0.75 µg/mL of 1 cannot inhibit the growth
of B. subtilis in LB. On the other hand, when B. subtilis cells
were cultured in 10−2 LB, using 1.5 µg/mL of 1 can decreased
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TABLE 2 | Cytotoxicity of 1 on mammalian cells.
IC50 against L929 IC50 against HK-2
96.5 µM (∼53 µg/mL) 98.15 µM (∼54 µg/mL)
the cell numbers to the lowest detectable limit after incubation
for 4 h, and also using 0.75 µg/mL of 1 showed inhibitory effect
on the growth of the cells (Figure 8B). These results indicated
that 1 has a better antibacterial activity against bacteria cultured
in the nutrient poor condition than that in the nutrient rich
condition. These results may due to rapid growth cells with
bigger size having much more FtsZ proteins than the slow
growing cells in the nutrient poor medium (Chien et al., 2012).
In addition, using 0.75 µg/mL of 1 can inhibit the cell division of
B. subtilis in both of the culture media. And the phenomena of
cell elongation were found sharper in LB than that of in 10−2 LB
(Figures 9C,D).
DISCUSSIONS
In the present study, we have found that compound 1 induced
filamentation in B. subtilis 168, showing that it inhibits bacterial
cytokinesis. The antibacterial tests showed that 1 possessed strong
and broad spectrum antibacterial activity. 1 was also found to
bind to FtsZ in vitro; it enhanced the assembly and bundling
of FtsZ protofilaments and decreased the GTPase activity of
FtsZ. In addition, sequencing data of 1-induced resistant mutants
revealed that this compound inhibit cell division by disturbing
the Z-ring formation through a direct interaction with FtsZ.
1 increased the light scattering intensity of FtsZ
protofilaments, indicating that it enhanced the polymerized
mass of FtsZ protofilaments and/or enhanced the bundling
of FtsZ protofilaments (Figure 4). Electron microscopic
analysis of the polymerization reaction showed that 1 strongly
increased the length of FtsZ protofilaments and the extent of
bundling of the protofilaments (Figures 4B,C). The increase
in the polymerization and bundling of FtsZ may be due
to the conformational switch to the high-affinity state that
enables polymer assembly (Elsen et al., 2012). The similar
enhancement of FtsZ polymerization can also be found in
some of FtsZ-targeting compounds, such as guanidinomethyl
biaryl derivatives, dimethoxyisoquinoline derivatives, PC190723
and its analogs (Andreu et al., 2010; Kaul et al., 2012, 2013b,
2015; Kelley et al., 2012). The assembly dynamics of FtsZ is
considered to be regulated by the GTPase activity of FtsZ
(Margolin, 2005). Some FtsZ inhibitors which can enhance the
FtsZ polymerization, such as PC190723 and Z3, were reported
to inhibit the GTPase activity of FtsZ (Margalit et al., 2004;
Haydon et al., 2008; Andreu et al., 2010). In this project, 1 was
also found to decrease the GTPase activity of FtsZ in a dose
dependent manner (Figure 4D and Supplementary Figure S2).
And around 58% inhibition of GTP hydrolysis was found in
the presence of 8 µg/mL (∼15 µM) of compound 1. Most of
the FtsZ inhibitors have been reported to suppress the GTPase
activity of FtsZ (Margalit et al., 2004; Chan et al., 2013; Sun
et al., 2014; Hurley et al., 2016). For example, zantrins inhibited
GTP hydrolysis with IC50 values ranging from 4 to 100 µM
(Margalit et al., 2004). 50% inhibition of GTP hydrolysis was
found in the presence of 37.8 µM of a 9-phenoxyalkylberberine
derivative (Sun et al., 2014). Similarly, quinuclidine and its
analogs inhibited the GTPase activity of SaFtsZ with an IC50
value of 37.5 µM (Chan et al., 2013). Thus the inhibitory effect
of 1 on GTPase activity was comparable with that of other
known FtsZ inhibitors. 1 was also found to disturb the secondary
FIGURE 8 | The growth curves of B. subtilis 168 in LB and 10−2 LB for 1. At time zero, samples of a growing culture of B. subtilis 168 in LB were incubated
with 1 at concentrations of 1.5 µg/mL (red), or 0.75 µg/mL (green; A). Samples of a growing culture of B. subtilis 168 in 10−2 LB were incubated with 1 at
concentrations of 1.5 µg/mL (red), or 0.75 µg/mL (green; B). Vehicle (1% DMSO; black) was included. Samples were removed at the time intervals indicated for the
determination of viable cell counts.
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FIGURE 9 | The morphology of B. subtilis 168 in LB or 10−2 LB. B. subtilis 168 cells cultured in LB for 24 h with absent (A) or 0.75 µg/mL of 1 (C). B. subtilis
168 cells cultured in 10−2 LB for 24 h with absent (B) or 0.75 µg/mL of 1 (D).
structure of FtsZ by monitoring CD spectra of FtsZ. Curcumin
known as a FtsZ inhibitor also showed similar effect on FtsZ
(Rai et al., 2008). The changes of secondary structure may be
the cause of disruption of FtsZ function. Tubulin is the closest
mammalian functional homolog to bacterial FtsZ. Twenty
micrometer of 1 does not disturb the polymerization of tubulin.
For the FtsZ protein, 3 µg/mL (∼6 µM) of 1 can effectively
enhance FtsZ polymerization (Figure 4A and Supplementary
Figure S1). These results suggest that 1 is a specific enhancer of
bacterial FtsZ polymerization without any effect on mammalian
tubulin.
1 can strongly inhibit the cell proliferation against all the tested
Gram-positive strains (including MRSA and VREF) with MIC
values from 0.75 to 3 µg/mL. And the inhibitory effects of 1
against these strains were slightly better or similar to that of some
reported FtsZ inhibitors. For Example, 9-phenoxyalkylberberine
derivative 2 inhibited the cell division with MIC values from
2 to 8 µg/mL against MRSA and VREF (Sun et al., 2014).
Quinuclidine 1 was found to inhibit the growth of S. aureus with
a MIC value of 24 µg/mL (Chan et al., 2015). PC190723 inhibited
the proliferation of S. aureus strains at∼1 µg/mL (Haydon et al.,
2008). In the other hand, 1 also showed strong inhibitory effects
against most of the tested Gram-negative strains (MIC values
from 1.5 to 6 µg/mL, Table 1). To date, there is only a few
FtsZ inhibitors reported to have potent or moderate anti-Gram-
negative bacterial activity. For instance, 9-phenoxyalkylberberine
derivative 2 and Quinuclidine 1 inhibited the growth of E. coli
with MIC values of 32 µg/mL (Sun et al., 2014; Chan et al.,
2015). Guanidinomethyl biaryl derivative 13 has MIC values from
2 to 32 µg/mL against the Gram-negative strains (Kaul et al.,
2012). Compared to the inhibitory effects against Gram-negative
strains, 1 have much stronger activities than that of reported FtsZ
inhibitors, which could be ascribed to this compound’s ability
to pass through the outer membrane of gram-negative bacteria
(Keffer et al., 2013; Kaul et al., 2014).
CONCLUSION
In summary, we identified a new small molecule which is
able to disrupt FtsZ dynamic specifically. This compound
effectively enhances FtsZ protein assembly but not tubulin
polymerization, blocks bacterial cytokinesis, and eventually
impairs bacterial cell division. Furthermore, 1 displays potent
antibacterial activity against drug-resistant pathogenic bacteria,
including MRSA, VREF and NDM-1 expressing E. coli. These
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merit characteristics of the compound coupled with minimal
cytotoxicity to mammalian cells make it be an attractive hit for
the design of innovative compounds that enhance specificity
target to FtsZ and have stronger antibacterial activities. Several
modifications on the structure of this thiazole orange derivative
are currently being made in our laboratories.
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